Prostate-specific antigen: Effect of pelvic irradiation

Radiology

Volumn 215, Issue 3, 2000, Pages 757-760

  Gripp, Stephan ^a   Haller, J Christoph ^a   Metz, Jürgen ^a   Willers, Reinhardt ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Anus, therapeutic radiology; Prostate; Prostate neoplasms, therapeutic radiology; Radiations, injurious effects; Rectum, therapeutic radiology

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ANTIGEN DETECTION; ANUS CANCER; ARTICLE; CLINICAL ARTICLE; HUMAN; PELVIS CANCER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIATION DOSE; RECTUM CANCER; SEMINAL VESICLE;

EID: 0034094968     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.215.3.r00jn09757     Document Type: Article

References (32)

1. Wang MC, Valenzuela LA, Murphy GP, Chu TM. Purification of a human prostate specific antigen. Invest Urol 1979; 17:159-163.
2. Stenman UH, Leinonen J, Alfthan H, Rannikko S, Tuhkanen K, Alfthan O. A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer. Cancer Res 1991; 51:222-226.
3. Catalona WJ, Richie JP, Ahmann FR, et al. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men. J Urol 1994; 151:1283-1290.
4. Ercole CJ, Lange PH, Mathisen M, Chiou RK, Reddy PK, Vessella RL. Prostatic specific antigen and prostatic acid phosphatase in the monitoring and staging of patients with prostatic cancer. J Urol 1987; 138:1181-1184.
5. Oesterling JE. Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J Urol 1991; 145:907-923.
6. Lattanzi JP, Hanlon AL, Hanks GE. Early stage prostate cancer treated with radiation therapy: stratifying an intermediate risk group. Int J Radiat Oncol Biol Phys 1997; 38:569-573.
7. D'Amico AV, Whittington R, Malkowicz SB, Schultz D, Tomaszewski JE, Wein A. Prostate-specific antigen failure despite pathologically organ-confined and margin-negative prostate cancer: the basis for an adjuvant therapy triai. J Clin Oncol 1997; 15:1465-1469.
8. Ben-Josef E, Shamsa F, Forman J. Predicting outcome of radiotherapy for prostate carcinoma. Cancer 1998; 82:1334-1342.
9. Oesterling JE, Chan DW, Epstein JI, et al. Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy. J Urol 1988; 139:766-772.
10. Stamey TA, Yang N, Hay AR, McNeal JE, Freiha FS, Redwine E. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 1987; 317:909-916.
11. Stenman UH, Leinonen J, Zhang WM, Finne P. Prostate-specific antigen. Semin Cancer Biol 1999; 9:83-93.
12. Partin AW, Criley SR, Subong EN, Zincke H, Walsh PC, Oesterling JE. Standard versus age-specific prostate specific antigen reference ranges among men with clinically localized prostate cancer: a pathological analysis. J Urol 1996; 155:1336-1339.
13. Oesterling JE, Cooner WH, Jacobsen SJ, Guess HA, Lieber MM. Influence of patient age on the serum PSA concentration: an important clinical observation. Urol Clin North Am 1993; 20:671-680.
14. Richie JP, Catalona WJ, Ahmann FR, et al. Effect of patient age on early detection of prostate cancer with serum prostate-specific antigen and digital rectal examination. Urology 1993; 42:365-374.
15. Nadler RB, Humphrey PA, Smith DS, Catalona WJ, Ratliff TI., Effect of inflammation and benign prostatic hyperplasia on elevated serum prostate specific antigen levels. J Urol 1995; 154:407-413.
16. Herschman JD, Smith DS, Catalona WJ. Effect of ejaculation on serum total and free prostate-specific antigen concentrations. Urology 1997; 50:239-243.
17. Oesterling JE, Rice DC, Glenski WJ, Bergstralh EJ. Effect of cystoscopy, prostate biopsy, and transurethral resection of prostate on serum prostate-specific antigen concentration. Urology 1993; 42:276-282.
18. Yuan JJ, Coplen DE, Petros JA, et al. Effects of rectal examination, prostatic massage, ultrasonography and needle biopsy on serum prostate specific antigen levels. J Urol 1992; 147:810-814.
19. Brawer MK, Schifman RB, Ahmann FR, Ahmann ME, Coulis KM. The effect of digital rectal examination on serum levels of prostatic-specific antigen. Arch Pathol Lab Med 1988; 112:1110-1112.
20. Crawford ED, Schutz MJ, Clejan S, et al. The effect of digital rectal examination on prostate-specific antigen levels. JAMA 1992; 267:2227-2228.
21. Zagars GK, Pollack A. Kinetics of serum prostate-specific antigen after external beam radiation for clinically localized prostate cancer. Radiother Oncol 1997; 44:213-221.
22. Zagars GK. The prognostic significance of a single serum prostate-specific antigen value beyond six months after radiation therapy for adenocarcinoma of the prostate. Int J Radiat Oncol Biol Phys 1993; 27:39-45.
23. Zelefsky MJ, Leibel SA, Wallner KE, Whitmore WF Jr, Fuks Z. Significance of normal serum prostate-specific antigen in the follow-up period after definitive radiation therapy for prostatic cancer. J Clin Oncol 1995; 13:459-463.
24. Chauvet B, Felix-Faure C, Lupsascka N, et al. Prostate-specific antigen decline: a major prognostic factor for prostate cancer treated with radiation therapy. J Clin Oncol 1994; 12:1402-1407.
25. Ritter MA, Messing EM, Shanahan TG, Potts S, Chappell RJ, Kinsella TJ. Prostatespecific antigen as a predictor of radiotherapy response and patterns of failure in localized prostate cancer. J Clin Oncol 1992; 10:1208-1217.
26. Willett CG, Zietman AL, Shipley WU, Coen JJ. The effect of pelvic radiation therapy on serum levels of prostate specific antigen. J Urol 1994; 151:1579-1581.
27. Zietman AL, Zehr EM, Shipley WU. The long-term effect on PSA values of incidental prostatic irradiation in patients with pelvic malignancies other than prostatic cancer. Int J Radiat Oncol Biol Phys 1999; 43:715-718.
28. Constine LS, Donaldson SS, McDougall IR, Cox RS, Link MP, Kaplan HS. Thyroid dysfunction after radiotherapy in children with Hodgkin's disease. Cancer 1984; 53:878-883.
29. Valdez IH, Wolff A, Atkinson JC, Macynski AA, Fox PC. Use of pilocarpine during head and neck radiation therapy to reduce xerostomia and salivary dysfunction. Cancer 1993; 71:1848-1851.
30. Samaan NA, Bakdash MM, Caderao JB, Cangir A, Jesse RH Jr, Ballantyne AJ. Hypopituitarism after external irradiation: evidence for both hypothalamic and pituitary origin. Ann Intern Med 1975; 83: 771-777.
31. Nishiyama K, Kozuka T, Higashihara T, Miyauchi K, Okagawa K. Acute radiation thyroiditis. Int J Radiat Oncol Biol Phys 1996; 36:1221-1224.
32. Aizawa T, Watanahe T, Suzuki N, et al. Radiation-induced painless thyrotoxic thyroiditis followed by hypothyroidism: a case report and literature review. Thyroid 1998; 8:273-275.